Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PDE6D | O43924 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25121524 | 1.00 | KDM4E (0.33) | KDM4EATML3MBTL1DUSP3HDAC4 | |
| SCHEMBL15832292 | 0.99 | KDM4E (0.34) | KDM4EATML3MBTL1DUSP3KMT2A | |
| SCHEMBL25965960 | 0.97 | KDM4E (0.31) | KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL25966317 | 0.96 | KDM4E (0.32) | KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL25965746 | 0.95 | DUSP3 (0.32) | KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL25121746 | 0.95 | DUSP3 (0.32) | KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL15840186 | 0.95 | KDM4E (0.31) | KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL25966131 | 0.94 | MAPT (0.34) | KDM4EATML3MBTL1DUSP3KMT2A | |
| SCHEMBL15840251 | 0.94 | ALDH1A1 (0.35) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL15840159 | 0.93 | L3MBTL1 (0.38) | KDM4EATML3MBTL1DUSP3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228523-A1 | Metal complexes | UDC IRELAND LTD (IE) | 2024-07-11 | — | — | US | disclosed |
| US-20240228523-A1 | Metal complexes | UDC IRELAND LTD (IE) | 2024-07-11 | — | — | US | disclosed |
| US-20230255106-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230255106-A1 | ORGANIC ELECTROLUMINESCENT APPARATUS | MERCK PATENT GMBH (DE) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228523-A1 | Metal complexes | MCU, IMMT, SOD1 | KDM4E 4540/4885ATM 4257/4885L3MBTL1 3190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.